Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Chronic treatment with rofecoxib but not ischemic preconditioning of the myocardium ameliorates early intestinal damage following cardiac ischemia/reperfusion injury in rats

Autor: László, Szilvia B., Lázár, Bernadette, Brenner, Gábor B., Makkos, András, Balogh, Mihály, Al-Khrasani, Mahmoud, Hutka, Barbara, Mohammadzadeh, Amir, Kemény, Ágnes, László, Terézia, Scheich, Bálint, Szabados, Tamara, Kenyeres, Éva, Giricz, Zoltán, Bencsik, Péter, Varga, Zoltán V., Novák, Julianna, Helyes, Zsuzsanna, Ferdinandy, Péter, Gyires, Klára, Zádori, Zoltán S.

Publikováno v: In Biochemical Pharmacology August 2020 178

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A dual role of lysophosphatidic acid type 2 receptor (LPAR2) in nonsteroidal anti-inflammatory drug-induced mouse enteropathy.

Autor: Hutka B; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.; Pharmacological and Drug Safety Research, Gedeon Richter Plc, Budapest, Hungary., Várallyay A; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary., László SB; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary., Tóth AS; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary., Scheich B; Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Paku S; Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Vörös I; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.; HCEMM-SU Cardiometabolic Immunology Research Group, Semmelweis University, Budapest, Hungary.; MTA-SE Momentum Cardio-Oncology and Cardioimmunology Research Group, Budapest, Hungary.; MTA-SE System Pharmacology Research Group, Budapest, Hungary., Pós Z; Department of Genetics, Cell and Immunobiology, Semmelweis University, Budapest, Hungary., Varga ZV; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.; HCEMM-SU Cardiometabolic Immunology Research Group, Semmelweis University, Budapest, Hungary.; MTA-SE Momentum Cardio-Oncology and Cardioimmunology Research Group, Budapest, Hungary., Norman DD; Department of Physiology, College of Medicine, University of Tennessee Health Science Center (UTHSC), Memphis, TN, USA., Balogh A; Institute of Translational Medicine, Semmelweis University, Budapest, Hungary., Benyó Z; Institute of Translational Medicine, Semmelweis University, Budapest, Hungary.; HUN-REN-SU Cerebrovascular and Neurocognitive Diseases Research Group, Budapest, Hungary., Tigyi G; Department of Physiology, College of Medicine, University of Tennessee Health Science Center (UTHSC), Memphis, TN, USA.; Institute of Translational Medicine, Semmelweis University, Budapest, Hungary., Gyires K; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary., Zádori ZS; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary. zadori.zoltan@semmelweis.hu.

Publikováno v: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2024 Feb; Vol. 45 (2), pp. 339-353. Date of Electronic Publication: 2023 Oct 10.